Admin

PCI Clinical Services Announces Additional Cryogenic Storage Capacity at its Rockford, IL Site

Mar 21, 2017

Philadelphia, USA – March 21, 2017. Leading pharmaceutical outsourcing services provider PCI Clinical Services (PCI) has announced a second phase 400 percent increase in Cyrogenic storage capabilities at its Rockford, Illinois site. The announcement follows PCI’s initial capital investment in specialist cryogenic storage in Rockford in November last year – investment that complements existing LN2 storage capability at its Bridgend site, a center of excellence for Clinical Trial services in the UK.   PCI’s continued investment reflects its commitment to meeting the growing need of the pharmaceutical and biotech market for large-scale, high quality storage of temperature-sensitive products and breakthrough ...

Read More

Growing market for generics and liberalization of Over-The-Counter medicines driving demand at CPhI Japan 2017

Mar 20, 2017

PIC/S membership accelerating international interest with market forecast to reach US$115bn by 2024   Amsterdam, 16th March 2017: CPhI Japan – organised by UBM EMEA and UBM Japan – returns to the Tokyo Big Sight Centre for its 16th edition from the 19th-21st April 2017. Gathering over 19,600 attendees and 550 exhibitors from 30 countries, the show will co-locate with ICSE, P-MEC, BioPh, and InnoPack. An ageing population, a growing generics market and liberalization of Over-The-Counter medicines make Japan an attractive destination for investments, particularly as the pharma industry undergoes legislative change, with the Government’s bid to cut healthcare expenditure.   Central to the ...

Read More

Contract manufacturer Pfizer CentreOne adds highly potent solid oral dose to its service portfolio

Mar 20, 2017

Second service addition by CMO this year Pfizer CentreOne, a global contract manufacturing organization (CMO) embedded within Pfizer, today announced that it has grown its service portfolio to include contract manufacturing of highly potent solid oral dose medicines. The service will be provided at the Pfizer Newbridge, Ireland, facility, which is now part of Pfizer CentreOne’s contract manufacturing network. The Pfizer site, near Dublin, has a long history of contract manufacturing and packaging highly potent solid oral drugs with advanced technologies. “We are pleased to add the Newbridge facility to our network to offer a wider array of services and ...

Read More

4th Peptides Conference

Mar 15, 2017

SMi Group’s 4th Peptides Conference will return to London on 6 & 7 July at the Holiday Inn Kensington Forum. Featuring 19 presentations, 2 exclusive workshops, and a new lineup of expert speakers, the 2017 agenda will provide you two days of invaluable knowledge and networking opportunities. In the past few years, new technological advancements have influenced the growth of the global peptide therapeutics market with an increased number of peptides now in the pipeline of many biotech companies. Thus, the two-day conference is set to explore the latest peptide therapeutics advances to to improve the peptide production, reduce manufacturing costs, and allow ...

Read More

In Vitro Diagnostics 2017

Mar 15, 2017

14th & 15th June 2017 Holiday Inn Kensington Forum, London, UK www.in-vitro-diagnostics.co.uk/ipi Sponsored by Qarad The third in its series, SMi is delighted to announce the return of In Vitro Diagnostics taking place in London on the 14th & 15th June 2017. Aimed at Managers/Heads and Directors of Regulatory Affairs, In Vitro Diagnostics, Clinical Affairs and Quality Assurance, IVDs 2017 will provide regulatory updates and key industry feedback from leading IVD manufacturers within this complex and ever-changing landscape. Through a series of presentations from handpicked industry experts and Notified Bodies, the 2017 event will prepare attendees for the challenging times ...

Read More